RU96120197A - APPLICATION OF THIOCETHENE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF HEPATITIS IN - Google Patents

APPLICATION OF THIOCETHENE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF HEPATITIS IN

Info

Publication number
RU96120197A
RU96120197A RU96120197/14A RU96120197A RU96120197A RU 96120197 A RU96120197 A RU 96120197A RU 96120197/14 A RU96120197/14 A RU 96120197/14A RU 96120197 A RU96120197 A RU 96120197A RU 96120197 A RU96120197 A RU 96120197A
Authority
RU
Russia
Prior art keywords
ylidene
acetate
isopropyl
carbamoyl
dithietan
Prior art date
Application number
RU96120197/14A
Other languages
Russian (ru)
Inventor
Ли Дзонг-Вук
Ю Дзоонг-Кеун
Ли Санг-Хо
Original Assignee
Юхан Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юхан Корпорейшн filed Critical Юхан Корпорейшн
Publication of RU96120197A publication Critical patent/RU96120197A/en

Links

Claims (2)

1. Применение производного тиокетена формулы (1) или его фармацевтически приемлемой соли для предотвращения или лечения гепатита B:
Figure 00000001

где Y является -CH2 - или -CH=CH-;
A является NH или O;
R1 является неразветвленной или разветвленной алкильной группой, имеющей 1 - 4 атомов углерода; и
когда A является O, R2 является неразветвленной или разветвленной алкильной группой, имеющей 1 - 4 атомов углерода, и когда A является NH, R2 является бензилом, 2-пиридилом, 2-тиазолилом, 4-метилтиазол-2-илом, 4-карбокситиазол-2-илом или 1,3,4-тиадиазол-2-илом.
1. The use of a thioketene derivative of the formula (1) or a pharmaceutically acceptable salt thereof for the prevention or treatment of hepatitis B:
Figure 00000001

where Y is —CH 2 - or —CH = CH—;
A is NH or O;
R 1 is an unbranched or branched alkyl group having 1 to 4 carbon atoms; and
when A is O, R 2 is a straight or branched alkyl group having 1 to 4 carbon atoms, and when A is NH, R 2 is benzyl, 2-pyridyl, 2-thiazolyl, 4-methylthiazol-2-yl, 4- carboxythiazol-2-yl or 1,3,4-thiadiazol-2-yl.
2. Применение по п.1, отличающееся тем, что производное тиокетена выбирают из группы, состоящей из диизопропил-2-(1,3-дитиол-2-илиден)малоната, изопропил-2-(1,3-дитиол-2-илиден) - 2-[N-(4-метилтиазол-2-ил)карбамоил]ацетата, изопропил-2-(1,3-дитиол-2-илиден) - 2-[N-(1,3,4-тиадиазол-2-ил)карбамоил] ацетата, изопропил-2-(1,3-дитиол-2-илиден)-2- -(2-пиридил)карбамоил ацетата, изопропил-2-(1,3-дитиэтан-2-илиден)-2-[N-(4-метилтиазол-2-ил)карбамоил] ацетата, изопропил-2-(1,3-дитиэтан-2-илиден)-2- [N-(2-пиридил)-карбамоил] ацетата, изопропил-2-(1,3-дитиэтан-2-илиден)-2-[N- (4-карбокситиазол-2-ил)карбамоил] ацетата, этил-2-(1,3-дитиэтан-2-илиден)-2- [N- (4-метилтиазол-2-ил)карбамоил] ацетата, изопропил-2-(1,3-дитиэтан-2-илиден-2-[N- (2-тиазолил)карбамоил] ацетата и изопропил-2-(1,3-дитиэтан-2-илиден)-2-(N-бензикарбамоил)ацетата. 2. The use according to claim 1, characterized in that the thioketene derivative is selected from the group consisting of diisopropyl-2- (1,3-dithiol-2-ylidene) malonate, isopropyl-2- (1,3-dithiol-2- ylidene) - 2- [N- (4-methylthiazol-2-yl) carbamoyl] acetate, isopropyl-2- (1,3-dithiol-2-ylidene) - 2- [N- (1,3,4-thiadiazole -2-yl) carbamoyl] acetate, isopropyl-2- (1,3-dithiol-2-ylidene) -2- - (2-pyridyl) carbamoyl acetate, isopropyl-2- (1,3-dithietan-2-ylidene ) -2- [N- (4-methylthiazol-2-yl) carbamoyl] acetate, isopropyl-2- (1,3-dithietan-2-ylidene) -2- [N- (2-pyridyl) -carbamoyl] acetate , isopropyl-2- (1,3-dithietan-2-ylidene) -2- [N- (4-carboxythiazol-2-yl) carbamoy ] acetate, ethyl 2- (1,3-dithietan-2-ylidene) -2- [N- (4-methylthiazol-2-yl) carbamoyl] acetate, isopropyl-2- (1,3-dithietan-2- ylidene-2- [N- (2-thiazolyl) carbamoyl] acetate and isopropyl-2- (1,3-dithietan-2-ylidene) -2- (N-benzicarbamoyl) acetate.
RU96120197/14A 1995-04-28 1996-04-26 APPLICATION OF THIOCETHENE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF HEPATITIS IN RU96120197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR95-10214 1995-04-28

Publications (1)

Publication Number Publication Date
RU96120197A true RU96120197A (en) 1998-12-27

Family

ID=

Similar Documents

Publication Publication Date Title
CA2039056A1 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
CA2044515A1 (en) Cyclic amide derivatives
IL106777A0 (en) Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride
KR920008006A (en) Unsaturated hydroxy alkylquinolinic acid as a leukotriene antagonist
JPS6479162A (en) Benzothiazole derivative
CA2053863A1 (en) Pyridazinone derivatives
RU97100151A (en) DERIVATIVES OF PIPERAZINE AS ANTAGONISTS 5HT1A
RU98117673A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF HYPERGLYCEMIA, MALIC ACID SALT 5- [4- [2- (N-METHYL-N- (2-Pyridyl) AMINO) ETOXY] BENZyl] THIAZOLI-IODIOLIENE-2-ILCENE-2-ILCENE-2-I-DIOLIDE-2-ILCENE-2-I-DOLIENE-2-ILCENE-2-ILCENE-2-I-2-Iolide-2-alkylene-2-imidene-2-dimene-2-amino-didene 2-amino-dione-in-2-d-imidene-2-amino-2-amino and 2-amino-2-inolin-2-amino inl and inlITin-2 in. TYPE II DIABETES TREATMENT FORM
CA2135890A1 (en) Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
RU97118591A (en) DERIVATIVES OF ACETAMIDE, METHOD FOR ITS PREPARATION AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS
RU98111511A (en) TRICYCLIC PYRAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION
RU97109847A (en) DERIVATIVES OF AMINOTHETRAZOLE, USEFUL AS A NITROGEN OXIDE SYNTHASE INHIBITORS
CA2250243A1 (en) Thiazoline acid derivatives
EP0806418A3 (en) Novel pyrimidine compound and anti-rotavirus agent
GB9602029D0 (en) New heterocyclic compounds
KR960705809A (en) Prodrugs of an inhibitor of HIV protease
JPS5334795A (en) Cephalosporin derivatives and their preparation
EP0391721A3 (en) Ocular hypotensive agents
RU96120197A (en) APPLICATION OF THIOCETHENE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF HEPATITIS IN
DK0777649T3 (en) N- [2- (pyrrolidinyl-1) -1-phenylethyl] acetamides as kappar receptor antagonists
KR920008005A (en) Hydroxyalkylquinoline Ether Acids as Leukotriene Antagonists
JPS52108980A (en) Carbostyril derivatives and their preparation
DE3474145D1 (en) Benzothiazolone derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
JPS5287164A (en) Thiazoline derivatives
RU2002119405A (en) PHARNESILTRANSPHERASE INHIBITORS